Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409968 · ClinicalTrials.gov registry record
BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 341
- Enrollment target
NCT00409968: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00409968 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 341 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409968 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 341 participants
- Enrollment target
Study Summary
This trial is referred to as the "umbrella trial". The BATTLE program consists of this umbrella trial plus four phase II protocols into which the umbrella patients are enrolled. Patients will first enroll in the BATTLE umbrella trial and undergo a tumor biomarker analysis that will be used to assign them to one of the four phase II studies. All patients enrolled in one of the phase II BATTLE protocols must be enrolled in this protocol.
Interventions
- PROCEDURE Tumor Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2006-11-27 |
| Est. Completion | 2019-10-31 |
What the finished NCT00409968 record still lists
NCT00409968 is an observational study that tracks outcomes without assigning an intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tumor Biopsy is the first listed.
NCT00409968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00409968 about?
NCT00409968 is a clinical study titled "BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)". This trial is referred to as the "umbrella trial". The BATTLE program consists of this umbrella trial plus four phase II protocols into which the umbrella patients are enrolled. Patients will first enroll in the BATTLE umbrella trial and undergo a tumor biomarker analysis that will be used to assign...
What is the current status of trial NCT00409968?
This trial is currently completed. The enrollment target is 341 participants. The study started on 2006-11-27. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT00409968?
The interventions under investigation include: Tumor Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00409968?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI